|Bid||10.85 x 0|
|Ask||10.95 x 0|
|Day's Range||10.84 - 11.22|
|52 Week Range||1.90 - 15.20|
|PE Ratio (TTM)||608.33|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.24|
Selling prices and per-gram production costs for cannabis will likely be defining factors in the success of Canadian cannabis producers (HMMJ). Most producers will be dealing with one purchaser in each province—the government—which will mean less bargaining power for producers. Pricing in each province will vary depending on demand and the objectives the provincial governments aim to achieve.
Aurora Cannabis Inc. and CanniMed Therapeutics Inc. announced today that following the successful take up and payment of approximately 86.8% of the issued and outstanding of CanniMed Shares, three Aurora Cannabis appointees will join the CanniMed Board of Directors, effective immediately.
NEW YORK, March 15, 2018-- via NetworkWire– NetworkNewsWire, a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc., ...
Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeutical
EDMONTON, Alberta and VANCOUVER, British Columbia, March 13, 2018-- via NetworkWire– Aurora Cannabis Inc. and PreveCeutical Medical Inc. today announced the grant of three permits by the Australian Government, ...
MedReleaf currently has a completed facility of 55,000 square feet in Markham, Ontario. As of the date of this writing, Phase 1 of the Bradford facility is complete, and together with the Markham facility, it has a cultivation capacity of 17,000 kilograms per year.
In this analysis, my focus will be on developing a perspective on Aurora Cannabis Inc’s (TSX:ACB) latest ownership structure, a less discussed, but important factor. A company’s ownership structure isRead More...
Currently, the company has 101,000 square feet of licensed capacity, which includes the recently added space of 57,000 square feet. The company also has two more expansion projects underway, which will build on to its current Part II facility.
In the earlier part of the series, we discussed how Aurora Cannabis (ACB) (ACBFF) plans to fund its production facility in Denmark. Aurora Cannabis is not the only Canadian cannabis-licensed producer to eye international markets. On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.
Last week, Aurora Cannabis (ACB) (ACBFF) announced that it completed a $230 million offering of convertible debentures with a maturity date of two years and an annualized interest of 5%, payable semi-annually. The debenture was issued at a conversion price of 13.05 Canadian dollars per common share, which was at a 13% discount to its closing price of 11.3 Canadian dollars on March 9.
Over the past few months, Aurora Cannabis (ACB)(ACBFF) has become one of the most actively traded stocks on TSX. Given this liquidity and other factors, last week, the S&P Dow Jones Canadian Index Services announced the rebalancing of its S&P/TSX Composite Index and the addition of Aurora Cannabis. Last week, Bloomberg Markets reported that Aurora Cannabis is exploring the option of listing on US exchanges to gain access to US investors.
Aurora Cannabis (ACB) (ACBFF), another licensed cannabis producer, is also doing its part to expand its capacity. Aurora Cannabis currently has a total licensed capacity of 95,000 square feet, which makes up ~5% of the company’s total capacity, including that which is under construction and in design. Aurora Cannabis has ~848,000 square feet of capacity under construction, primarily in the provinces of Alberta and Quebec.
It’s natural that companies are anticipating high provincial demand for recreational cannabis (HMLSF) and ramping up their production capacities. Canopy Growth (WEED) recently said, “It will take two years and possibly longer to rollout the full network of regulated cannabis retail stores that is required to satisfy consumer demand.” This also gives producers time to gradually build their capacities. Let’s look at what Canopy Growth is up to on that front.
Ahead of the legalization of recreational cannabis, companies are ramping up their production capacities. Currently, Canada has a total of 91 licensed producers, of which 48 are in the province of Ontario. How a province goes about selecting its supplier will be critical for big and small players alike.
In anticipation of recreational cannabis’s legalization at the federal level in Canada (HMMJ), provinces have been doing their best to prepare. In most provinces, government agencies will oversee the procurement, distribution, and retail of recreational cannabis. On the other hand, government agencies in some provinces will oversee the procurement and distribution but will also allow private retailers to sell recreational cannabis to customers. These provinces include British Columbia, Alberta, Saskatchewan, and Manitoba.